GlobeNewswire 2021-09-22 Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccin...
GlobeNewswire 2021-09-21 Capital Increase in Genmab as a Result of Employee Warrant Exercise
GlobeNewswire 2021-09-20 Genmab and Seagen Announce FDA Accelerated Approval for TIVDAK™ (tisotumab vedotin-tftv) in Previous...
GlobeNewswire 2021-09-20 Pfizer and BioNTech Announce Positive Topline Results from Pivotal Trial of COVID-19 Vaccine in Chil...
GlobeNewswire 2021-09-18 FDA Advisory Committee Votes Unanimously in Favor of COMIRNATY® Booster for Emergency Use in People ...
GlobeNewswire 2021-08-27 Joint Communiqué: BioNTech Evaluates mRNA Vaccine Manufacturing Solutions in Rwanda and Senegal to I...
GlobeNewswire 2021-08-26 Pfizer and BioNTech Announce Collaboration with Brazil’s Eurofarma to Manufacture COVID-19 Vaccine D...
GlobeNewswire 2021-08-25 Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S...
GlobeNewswire 2021-08-23 Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years...
GlobeNewswire 2021-08-16 Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID...
GlobeNewswire 2021-08-12 Bolt Biotherapeutics Reports Second Quarter 2021 Financial Results and Provides Business Highlights
GlobeNewswire 2021-08-11 Genmab Announces Financial Results for the First Half of 2021
GlobeNewswire 2021-08-09 BioNTech Announces Second Quarter 2021 Financial Results and Corporate Update
GlobeNewswire 2021-08-04 BioNTech Completes Acquisition of Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing ...
GlobeNewswire 2021-07-26 BioNTech Provides Update on Plans to Develop Sustainable Solutions to Address Infectious Diseases on...
GlobeNewswire 2021-07-23 Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vacci...
GlobeNewswire 2021-07-21 Major Shareholder Announcement
GlobeNewswire 2021-07-21 Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccin...
GlobeNewswire 2021-07-21 Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Second Quarter of 2021
GlobeNewswire 2021-07-19 BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Ga...
GlobeNewswire 2021-06-22 Genmab Announces that Janssen has Received European Marketing Authorizations for DARZALEX® (daratumu...
GlobeNewswire 2021-06-18 BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients wi...
GlobeNewswire 2021-06-10 Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation...
GlobeNewswire 2021-06-02 Genmab and Bolt Biotherapeutics Announce Oncology Research and Development Collaboration
GlobeNewswire 2021-05-28 Pfizer and BioNTech Receive First Authorization in European Union for COVID-19 Vaccine in Adolescent...